Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Avixgen a subsidiary of DxVx announced on the th that it has signed a licensingout agreement worth approximately USD million with a US biotechnology company for its nextgeneration drug delivery platform
The Health Sciences Authority HSA has approved Sanofi and AstraZenecas BEYFORTUS nirsevimab for the prevention of respiratory syncytial virus RSV lower respiratory tract disease in newborns and infants
SineuGene Therapeutics Co Ltd clinicalstage biotechnology company that mainly focuses on gene therapies for neurological disorders announced today that Chinas National Medical Products Administration NMPA
Testing technologies play a pivotal role in disease diagnosis Currently flow cytometers are widely used in the field of biomedicine and are considered the gold standard for diagnosing blood diseases such as leukaemia
Nanjing Leads Biolabs Co Ltdtoday announced the successful completion of patient enrollment in the ongoing singlearm pivotal registrational clinical trial CTR for Opamtistomig LBL a novel PDLBB bispecific antibody
Clarivate Plca leading global provider of transformative intelligence today announced the beta launch of its AIpowered Regulatory Assistant within Cortellis Regulatory Intelligence This new capability is designed
Everest Medicines a biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced that etrasimod VELSIPITY
The European Medicines Agency has granted orphan designation to rilzabrutinib a reversible covalent Brutons tyrosine kinase BTK inhibitor for IgGrelated disease IgGRD
Sarepta Therapeutics Inc the leader in precision genetic medicine for rare diseases today announced that it has sold shares of common stock of Arrowhead Pharmaceuticals Inc
In a landmark moment for global hepatology and Indian pharmaceutical innovation Shilpa Medicare Limited has secured the worlds first regulatory approval from Indias Central Drugs Standard Control Organization CDSCO
